Glenview State Bank Trust DEPT. decreased its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 1.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,130 shares of the pharmacy operator’s stock after selling 999 shares during the period. Walgreens Boots Alliance accounts for about 2.1% of Glenview State Bank Trust DEPT.’s investment portfolio, making the stock its 18th largest holding. Glenview State Bank Trust DEPT.’s holdings in Walgreens Boots Alliance were worth $4,257,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Hudock Capital Group LLC increased its holdings in shares of Walgreens Boots Alliance by 0.5% in the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 6 shares in the last quarter. Westside Investment Management Inc. increased its holdings in shares of Walgreens Boots Alliance by 10.4% in the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 125 shares in the last quarter. IHT Wealth Management LLC increased its holdings in shares of Walgreens Boots Alliance by 46.3% in the second quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock valued at $135,000 after buying an additional 2,199 shares in the last quarter. Bristlecone Advisors LLC bought a new position in shares of Walgreens Boots Alliance in the third quarter valued at $135,000. Finally, Private Vista LLC grew its position in Walgreens Boots Alliance by 6,403.7% during the 2nd quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock worth $140,000 after purchasing an additional 574,218 shares in the last quarter. 61.41% of the stock is currently owned by hedge funds and other institutional investors.

WBA has been the topic of several research analyst reports. Deutsche Bank initiated coverage on shares of Walgreens Boots Alliance in a research report on Monday, December 4th. They set a “hold” rating and a $78.00 price objective on the stock. Raymond James Financial reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Wednesday, September 27th. BidaskClub upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, August 30th. Leerink Swann cut shares of Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 1st. Finally, Loop Capital set a $90.00 price objective on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Thursday, October 26th. One research analyst has rated the stock with a sell rating, nine have given a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $86.47.

Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $71.72 on Thursday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.59 and a current ratio of 1.07. Walgreens Boots Alliance Inc has a fifty-two week low of $63.82 and a fifty-two week high of $88.00. The company has a market cap of $71,030.00, a price-to-earnings ratio of 14.09, a PEG ratio of 1.28 and a beta of 1.22.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.21 by $0.10. The firm had revenue of $30.15 billion during the quarter, compared to analysts’ expectations of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. Walgreens Boots Alliance’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same period in the prior year, the company posted $1.07 earnings per share. sell-side analysts predict that Walgreens Boots Alliance Inc will post 5.54 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Monday, November 13th were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.23%. The ex-dividend date was Friday, November 10th. Walgreens Boots Alliance’s dividend payout ratio is presently 42.33%.

Walgreens Boots Alliance declared that its board has authorized a share buyback program on Wednesday, October 25th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the pharmacy operator to buy shares of its stock through open market purchases. Shares buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.

In other news, Director John Anthony Lederer bought 20,000 shares of the business’s stock in a transaction on Thursday, October 26th. The stock was purchased at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the transaction, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now directly owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. Corporate insiders own 14.80% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was posted by Watch List News and is the property of of Watch List News. If you are accessing this piece on another publication, it was illegally copied and republished in violation of United States & international copyright and trademark law. The legal version of this piece can be accessed at https://www.watchlistnews.com/walgreens-boots-alliance-inc-wba-position-reduced-by-glenview-state-bank-trust-dept/1763183.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with Analyst Ratings Network's FREE daily email newsletter.